ALEJANDRO HERNANDEZ CAMBA

Profesor Colaborador

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Javier Pérez Gisbert

Tenure Professor

Universidad Autónoma de Madrid

SPAIN

View details

Manuel Barreiro de Acosta

Profesor Asociado

Universidade de Santiago de Compostela

SPAIN

View details

Jose Luis Cabriada

Head of Department

Osakidetza Servicio Vasco de Salud

SPAIN

View details

NOEMI MANCEÑIDO MARCOS

Profesor colaborador del Grado de Medicina

Universidad Autónoma de Madrid

SPAIN

View details

Laura de Armas Rillo

Universidade Europeia

SPAIN

View details

MARIA ESTEVE

Head of the Department

SPAIN

View details

Iván Ferraz-Amaro

Universidad de la Laguna

SPAIN

View details

Fernando Gomollón

SPAIN

View details

María Chaparro

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

ALEJANDRO HERNANDEZ CAMBA

Research Interests

Explore related searches

Contact this professor

Articles (10)

Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP

Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry

Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease

Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)

Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab

Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project

Apolipoprotein C3 is Downregulated in Patients with Inflammatory Bowel Disease

Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry

Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study

Collaborators (9)

Javier Pérez Gisbert

Manuel Barreiro de Acosta

Jose Luis Cabriada

NOEMI MANCEÑIDO MARCOS

Laura de Armas Rillo

MARIA ESTEVE

Iván Ferraz-Amaro

Fernando Gomollón

María Chaparro

Make your next move.